The periodic disappearance of certain medicines from the shelves of Bulgarian pharmacies is completely legal and regulated according to European rules and is a consequence of the so-called "parallel export," President of the National Pharmacy Chamber Anton Valev told the BNR. According to him, countries affected need to demand changes to this part of the European Union treaty.
"A company sells a specific drug for 10 euros in Germany, for example. The same medicine on the Bulgarian market costs 5 euros, so that Bulgarians could afford it. This way the drug becomes very profitable for some exporters - whether it would be a Bulgarian company or a German company or a cooperation between a Bulgarian and a German company. They could buy all the quantities from the Bulgarian market and sell them on the German market at a price of 8 euros, for example, thus making huge profits," Valev explained the mechanism of the phenomenon.
For the first time, the Bulgarian National Radio (BNR) is hosting the annual Public Broadcasters International conference . The conference brings together public media bosses and executives from 24 countries across five continents. The theme..
Bulgaria supports the start of EU accession negotiations with Ukraine and Moldova, said Bulgaria’s Minister of Foreign Affairs Georg Georgiev during the EU Foreign Affairs Council held in Luxembourg. European Commissioner for Enlargement Marta Kos..
President Rumen Radev has issued decrees appointing Bulgarian ambassadors to the Kingdom of Belgium, the Kingdom of the Netherlands and the Republic of Kazakhstan. The decrees were published in the State Gazette, reported BTA. Natalia Evgenieva..
On Tuesday , the lowest temperatures will be between 2 and 7°C. In the valleys and high fields the temperature can drop to minus 2°C;..
Bulgaria, Greece and Romania have finalized a memorandum for joint cooperation on new transport projects, said European Commissioner for..
The European Public Prosecutor’s Office has carried out searches in the Municipality of Plovdiv and in a company suspected of public..
+359 2 9336 661